Ex-Gov’t Foe Joins Trump, RFK Jr.’s HHS To Lead Psychedelics Policy: What It Means For Investors – Compass Pathways (NASDAQ:CMPS), ATAI Life Sciences (NASDAQ:ATAI)
Matthew Zorn, an attorney known for suing the federal government over cannabis and psychedelics policy, is now joining it. Zorn has been appointed Deputy General Counsel at the U.S. Department of Health and Human Services (HHS) under Secretary Robert F. […]